A4M Anti-Aging Conference and Exposition,
Las Vegas, Nevada, December 2004.

Gerontological Society of America, Washington DC, November 2004.

U.S. Food and Drug Administration, "Public Meeting on Premarket Notification for New Dietary Ingredients," College Park, Maryland, 15 November 2004.

Alzheimer's Association, Philadelphia, July 2004.

American Aging Association,
"Molecular Mechanisms of Aging as Modulated by Genes, Hormones, and Oxidative Events,"
St. Petersburg, Florida, June 2004.

Oxygen Club of California, "Oxidants and Antioxidants in Biology," Santa Barbara, California, March 2004.

International Association of Biomedical Gerontology 10th Congress,
"Strategies for Engineered Negligible Senescence:
Reasons Why Genuine Control of Aging may be Foreseeable,"
Cambridge, England, September 2003.
*** Presented poster: "Flow Chart of Biochemical and Physiological Interactions In Human Aging."

American Aging Association,
"Aging: from Molecules to Humans: Translational Research on Aging,"
Baltimore, June 2003.
*** Presented poster: "Flow Chart of Biochemical and Physiological Interactions In Human Aging."

Free Radical Underground, "Redox Regulation, Oxidative Stress, and Skeletal Muscles",
University of Florida, Gainesville, January 2003.

A4M Anti-Aging Conference and Exposition,
Las Vegas, Nevada, December 2002.

Buck Institute Community Seminar Program: "Cancer and Aging," Novato, California, December 2002.

Society for Free Radical Biology and Medicine, (Formerly: The Oxygen Society) Ninth Annual Meeting, San Antonio, Texas, November 2002.

Linkoping University, Department of Pathology, Linkoping, Sweden, October 2002.
*** Invited speaker: "Designing therapies to repair the pathological changes of aging."

SMi Conference Series, "Anti-Ageing Therapies," London, England, October 2002.
*** Invited speaker: "Mitochondria and Lysosomes in Primary Mechanisms of Human Ageing: Developing drugs and gene therapies for post-mitotic cells."

Strategic Research Institute, "Anti-Aging Drug Discovery and Development Summit: The Molecular Basis of Aging and Commercial Prospects for Therapeutics in Aging Intervention." San Francisco, California, October 2002.
*** Invited speaker: "Anti-aging drug discovery opportunities in Mitochondria and Lysosomes."

Buck Institute Symposium 2002: "Neuroendocrine Systems and Lifespan Determination," Novato, California, September 2002.

Ellison Medical Foundation Symposium on the Biology of Aging, "Global Infectious Diseases and the Biology of Aging," Stanford University School of Medicine, September 2002.

American Aging Association, "Aging: from Molecules to Humans: Translational Research on Aging," San Diego, June 2002.
*** Presented poster: "Flow Chart of Biochemical Interactions Causing Human Aging."

Oxygen Club of California, "Oxidants and Antioxidants in Biology," Santa Barbara, California, March 2002.
*** Presented poster: "Flow Chart of Biochemical Interactions Causing Human Aging."

Gerontological Society of America, Chicago, Nov 2001.
*** Presented poster: "Human senescence: Primary causes and interactions flow chart."

Center for Research and Education on Aging (CREA) "The New Science of Aging: A Symposium and Fair," Berkeley, California, October 2001.
*** Presented lecture: "Intervening into Aging Processes."

International Association of Biomedical Gerontology, 9th Congress, Vancouver, British Columbia, Canada, June 2001.
*** Presented poster: "Human senescence: Primary causes and interactions flow chart."

American Aging Association, "Successful Aging: Exploring Interventions for Maximizing Lifespan and Healthspan," Madison, Wisconsin, May - June 2001.
*** Presented poster: "Human senescence: Primary causes and interactions flow chart."

Buck Institute/MitoKor Advanced Course on Mitochondrial Physiology, Novato, California, May 2001.

Understanding the Drug Development Process, Hum Bio 20, Stanford University, April - May 2001.

Second International Conference on Oxidative Stress and Aging: "Technologies for Assessment and Intervention Strategies", Maui, Hawaii, April 2001.

The Stanford University Symposium on Aging: Biology, Disease, and Economics, March 13, 2001.

Oxygen Club of California, "Oxidants and Antioxidants in Biology," Santa Barbara, California, March 2001.

Mitochondria 2001, San Diego, California, March 2001.

American Association for the Advancement of Science, 2001 Genome Seminar: Beyond the Human Genome, San Francisco, February 2001.

Gerontological Society of America, Washington DC, November 2000.

Ellison Medical Foundation Symposium on the Biology of Aging, "Differential Gene Expression in Development and Aging," California Institute of Technology, October 2000.

Symposium on Organisms with Slow Aging (SOSA), Andrus Gerontology Center, University of Southern California, September 2000.

American Aging Association, "Stress in Aging: Models, Mechanisms and Interventions," Boston, June 2000.

American Federation for Aging Research, Boston, June 2000.

Center for Clinical Sciences Research: From Bench to Bedside, Stanford University, May 2000.

Understanding the Drug Development Process, Hum Bio 20, Stanford University, April - May 2000.

Diseases of Aging and Gene Therapy, Mol Pharm 241 (Blau, Nolan, Porzig), Stanford University, March - May 2000.
*** Presented class lecture: "Mitochondria, Free Radicals, and Aging."

NIH Mitochondria Mini-symposium, Bethesda, March 2000.

Gordon Conference on the Biology of Aging, "Molecular Mechanisms of Aging: Metabolic Control and Resistance to Stress," Ventura, California, Jan - Feb 2000.

Gerontological Society of America, San Francisco, November 1999.

Ellison Medical Foundation Symposium on the Biology of Aging, "Nucleic and Epinucleic Modifications in Evolution and Aging," Seattle, October 1999.

Drug Discovery, Mol Pharm 240 (Mochly-Rosen, Cimprich), Stanford University, Sep - Nov 1999.

Buck Institue for Age Research: Inaugural Symposium on Aging, Novato, California, September 1999.

Computational Molecular Biology, MIS 214 (Altman, Koza), Stanford University, March - May 1999.

Gene Therapy: Prospects for the Next Decade, Stanford University, Mar 1999.

Computational Structural Biology: Protein Simulation and Structure Prediction, SB 228 (Levitt), Stanford University, Jan - Mar 1999.

Genetics Logic and Methods, Gen 222 (Myers, Vollrath), Stanford University, Jan - Feb 1999.

Drug-receptor Interactions and Drug Design, Mol Pharm 250 (Jardetzky), Stanford University, Jan - Mar 1999.
*** Presented class lecture: "Stucture-Based Design of a Dimeric Zinc Finger Protein."

More Advanced Genetics, Gen 204 (Botstein, Kim, Stearns, Villenueve), Stanford University, Jan - Feb 1999.

Ellison Medical Foundation Symposium on the Biology of Aging, "Evolution of Gene Action in Aging and Senescence," San Francisco, October 1998.

Computational Molecular Biology: Bioinformatics, Biochem 218 (Brutlag), Stanford University, Sep - Nov 1998.

Advanced Genetics, Gen 203 (Botstein, Kim, Stearns, Villeneuve), Stanford University, Sep- Nov 1998.

Scientific Data Mining & Bioinformatics, UC Berkeley Extension, Sep - Nov 1998.
*** Presented class lecture: "Gene Expression Micro-Arrays to study Aging: A New Challenge for Data Mining and Bioinformatics."

Molecular Biology of Gene Therapy, Mol Pharm 231 (Nolan, Blau), Stanford University, Mar - Jun 1998.

Design and Conduct of Clinical Trials, PRECEPT, Stanford University, Jan - Mar 1998.

Advanced Genetics, Gen 203 (Kim, Stearns, Villeneuve), Stanford University, Sep- Nov 1997.

Microbial Development, Dev Bio 211 (Shapiro, Kaiser), Stanford University, Sep- Nov 1997.

Introductory Immunology 131 (Shaw), Stanford University, Jun-Aug 1997.

Advanced Immunology 202/212 (Chien), Stanford University, Mar-May 1997.